MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancerBing Li, Gerald Schmit-Bindert, Fei Ke et al.|Lung Cancer|2013Cited by 178
Long non-coding RNA <i>UCA1</i> induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in <i>EGFR</i>-mutant non-small cell lung cancerNingning Cheng, Fred R. Hirsch, Weijing Cai et al.|Oncotarget|2015Cited by 149
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysisTao Jiang, Caicun Zhou, Meng Qiao et al.|Cancer Immunology Immunotherapy|2018Cited by 99
T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patientsWěi Li, Gerald Schmid‐Bindert, Shengxiang Ren et al.|Lung Cancer|2014Cited by 94
Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancerNingning Cheng, Caicun Zhou, Xuefei Li et al.|Oncology Reports|2014Cited by 82